Oragenics (OGEN) Return on Assets (2011 - 2026)

Oragenics (OGEN) has 16 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Assets rose 3.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 3.0% YoY) and the FY2025 annual result came in at 0.02%, up 2.0% from the prior year.
• Return on Assets declined to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2022 to a low of 0.06% in Q2 2024.
• A 5-year average of 0.02% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2024 — Return on Assets slipped 5 bps — and 2025, when it increased 4 bps.
• Tracing OGEN's Return on Assets over 5 years: stood at 0.01% in 2022, then sank by 257 bps to 0.03% in 2023, then gained by 1 bps to 0.03% in 2024, then jumped by 72 bps to 0.01% in 2025, then decreased by 30 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.